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Abstract: 19 
 Energy-coupling factor type (ECF-transporters) represent trace nutrient acquisition systems. 20 
Substrate binding components of ECF-transporters are membrane proteins with extraordinary affinity, 21 
allowing them to scavenge trace amounts of ligand. A number of molecules have been described as 22 
substrates of ECF-transporters, but an involvement in iron-acquisition is unknown. Host-induced iron 23 
limitation during infection represents an effective mechanism to limit bacterial proliferation. We 24 
identified the iron-regulated ECF-transporter Lha in the opportunistic bacterial pathogen 25 
Staphylococcus lugdunensis and show that the transporter is specific for heme. The recombinant 26 
substrate-specific subunit LhaS accepted heme from diverse host-derived hemoproteins. Using 27 
isogenic mutants and recombinant expression of Lha, we demonstrate that its function is independent 28 
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of the canonical heme acquisition system Isd and allows proliferation on human cells as sources of 29 
nutrient iron. Our findings reveal a unique strategy of nutritional heme acquisition and provide the first 30 
example of an ECF-transporter involved in overcoming host-induced nutritional limitation. 31 
 32 
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Background: 36 
 Trace nutrients such as metal ions and vitamins are needed as prosthetic groups or cofactors in 37 
anabolic and catabolic processes and are therefore crucial for maintaining an active metabolism. Metal 38 
ions such as iron, manganese, copper zinc, nickel and cobalt must be acquired from the environment 39 
by all living organisms. In contrast many prokaryotes are prototrophic for vitamins like riboflavin, 40 
biotin and vitamin B12. However, these biosynthetic pathways are energetically costly [1], and 41 
prokaryotes have developed several strategies to acquire these nutrients from the environment. ABC 42 
transporters of the Energy-coupling factor type (ECF-transporters) represent highly effective trace 43 
nutrient acquisition systems [2, 3]. In contrast to the substrate-binding lipoproteins/periplasmic 44 
proteins of conventional ABC transporters, the specificity subunits of ECF transporters (ECF-S) are 45 
highly hydrophobic membrane proteins (6-7 membrane spanning helices) [2]. ECF-S subunits display 46 
a remarkably high affinity for their cognate substrates in the picomolar to the low nanomolar range, 47 
which allows scavenging of smallest traces of their substrates from the environment [4]. Whether ECF 48 
type transporters can be used to acquire iron or iron-containing compounds is unknown. 49 
 The dependency of bacteria on trace nutrients is exploited by the immune system to limit 50 
bacterial proliferation by actively depleting nutrients from body fluids and tissues. This strategy is 51 
referred to as “nutritional immunity” [5, 6]. In this regard, depletion of nutritional iron (Fe2+/Fe3+) is 52 
crucial as iron is engaged in several metabolic processes such as DNA replication, glycolysis, and 53 
respiration [7, 8]. Extracellular iron ions are bound by high-affinity iron-chelating proteins such as 54 
lactoferrin and transferrin found in lymph and mucosal secretions and in serum, respectively. 55 
However, heme is a rich iron source in the human body and invasive pathogens can access this heme 56 
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pool by secreting hemolytic factors to release hemoglobin or other hemoproteins from erythrocytes or 57 
other host cells. Bacterial receptors then extract heme from the hemoproteins. This is followed by 58 
import and degradation of heme to release the nutritional iron. To date, several heme acquisition 59 
systems of different Gram-positive and Gram-negative pathogens have been characterized at the 60 
molecular level (see [9] for an excellent review).  61 
 Staphylococci are a major cause of healthcare-associated infections that can lead to morbidity 62 
and mortality. The coagulase-positive Staphylococcus aureus represents the best-studied and most 63 
invasive species. Coagulase-negative staphylococci (CoNS) are regarded as less pathogenic than S. 64 
aureus and infections caused by CoNS are normally subacute and less severe. In this regard, the CoNS 65 
Staphylococcus lugdunensis represents an exception. S. lugdunensis infections frequently show a 66 
fulminant and aggressive course of disease that resembles that of S. aureus. Strikingly, S. lugdunensis 67 
is associated with a series of cases of infectious endocarditis [10]. The reasons for the apparently high 68 
virulence potential of S. lugdunensis remains largely elusive and few virulence factors have been 69 
identified so far. In this respect, it is interesting to observe that S. lugdunensis, unlike other 70 
staphylococci but similar to S. aureus, encodes an iron-dependent surface determinant locus (Isd) 71 
system [11, 12]. Isd facilitates the acquisition of heme from hemoglobin and can be regarded as a 72 
hallmark of adaption towards an invasive lifestyle. However, to ensure continuous iron acquisition 73 
within the host, many pathogens encode multiple systems to broaden the range of iron-containing 74 
molecules that can be acquired [13]. 75 
 Here we report the identification of an iron-regulated ECF-type ABC transporter (named 76 
LhaSTA) in S. lugdunensis. We found LhaSTA to be specific for heme, thus representing a novel 77 
strategy to overcome nutritional iron limitation. Recombinant LhaS was able to take up heme from 78 
several host hemoproteins such as hemoglobin, myoglobin or hemopexin. Consistent with these data, 79 
LhaSTA expression allowed proliferation of S. lugdunensis in the presence of these iron sources as 80 
well as human erythrocytes or cardiac myelocytes as a sole source of nutrient iron. Our data indicate 81 
that LhaSTA function is independent of the presence of surface-displayed hemoprotein receptors 82 
suggesting Isd-independent acquisition of heme from host hemoproteins. Our work identifies LhaSTA 83 
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as the first ECF transporter that facilitates iron acquisition, thus participating to overcome host 84 
immune defenses. 85 
 86 
Results: 87 
LhaSTA encodes an iron regulated ECF transporter 88 
 The isd locus of S. lugdunensis shows several characteristics that distinguish it from the locus 89 
of S. aureus. Amongst these is the presence of three genes that encode a putative ABC transporter and 90 
are located between isdJ and isdB (Fig. 1A) [11]. Analysis of the open reading frame using Pfam [14] 91 
revealed that the three adjacent genes encode components of a putative ECF-transporter, namely a 92 
specificity subunit (lhaS - SLUG_00900), a transmembrane subunit (lhaT - SLUG_00910) and an 93 
ATPase (lhaA - SLUG_00920), and they might be part of a polycistronic transcript. The location 94 
within the isd operon suggested a role of the transporter in iron acquisition. Bacteria sense iron 95 
limitation using the ferric uptake repressor (Fur) which forms DNA-binding dimers in the presence of 96 
iron ions [15]. Under iron limitation, Fe dissociates from Fur and the repressor loses affinity for its 97 
consensus sequence (fur box) allowing transcription. Interestingly, a fur-box was located upstream of 98 
lhaS (Fig. 1A). qPCR analysis in S. lugdunensis N920143 revealed that the expression of lhaS and 99 
lhaA increased ~21 and ~12 fold, respectively, in the presence of the Fe-specific chelator EDDHA 100 
(Fig. 1B). The effect of EDDHA could be prevented by addition of FeSO4 (Fig. 1B). This confirmed 101 
iron-dependent regulation and suggested that LhaSTA is involved in iron acquisition.  102 
 103 
LhaSTA allows bacterial proliferation on heme as a source of nutrient iron 104 
 LhaSTA is encoded within the isd operon and the Isd system facilitates the acquisition of 105 
heme from hemoglobin [12, 16]. Therefore, we speculated that LhaSTA might also be involved in the 106 
transport of heme. To test this, we used allelic replacement and created isogenic deletion mutants in S. 107 
lugdunensis N920143 lacking either lhaSTA or isdEFL the latter of which encodes the conventional 108 
lipoprotein-dependent heme transporter of the isd locus. Further we created a ΔlhaSTA∆isdEFL double 109 
mutant. In the presence of 20 µM FeSO4 all strains showed similar growth characteristics (Fig. 1C). 110 
The two single mutants had a slight growth defect compared to wild type when heme was the only iron 111 
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source. However, the ΔlhaSTA∆isdEFL mutant showed a significant growth defect under these 112 
conditions (Fig. 1D). These data strengthen the hypothesis that LhaSTA is a heme transporter. 113 
 114 
LhaS binds heme 115 
 To confirm the specificity of LhaSTA, we heterologously produced the substrate-specific 116 
component LhaS in E. coli and purified the protein. We observed that the recombinant protein showed 117 
a distinct red color when purified from E. coli grown in rich LB medium, which contains heme due to 118 
the presence of crude yeastextract [17] (Fig. 2A). The absorption spectrum of the protein showed a 119 
Soret peak at 415 nm and Q-band maxima at 537 and 568 nm, suggesting histidine coordination of the 120 
heme group. Both the visible color and the spectral peaks were absent when LhaS was purified from 121 
E. coli grown in heme-deficient RPMI medium (Fig. 2A). We conducted MALDI TOF analysis of 122 
holo-LhaS purified from E. coli grown in LB and identified two peaks, one of which corresponds to 123 
full length recombinant LhaS (24074.437 Da expected weight), and the other to heme (616,1767 Da 124 
expected weight). Importantly, the heme peak was not detectable when LhaS was purified from RPMI 125 
(Fig 2B and 2C). Furthermore, ESI MS confirmed the presence of heme only in LhaS samples purified 126 
from LB (Figure 2 - figure supplement 1). Using the extinction coefficients of LhaS and heme we 127 
calculated a heme-LhaS binding stoichiometry of 1:0.6 for the complex isolated from heme containing 128 
medium.  129 
 130 
LhaSTA represents an iron acquisition system 131 
 Next, we sought to investigate whether LhaSTA represents a functional and autonomous iron 132 
acquisition system. LhaSTA is located within the isd locus of S. lugdunensis, which, besides the 133 
conventional heme membrane transporter IsdEFL, also encodes the hemoglobin receptor IsdB and the 134 
cell wall-anchored proteins IsdJ and IsdC. Furthermore, the locus encodes the putative 135 
secreted/membrane-associated hemophore IsdK, whose role in heme binding or transport is currently 136 
unknown [16], and the autolysin atl remodeling the cell wall [18]. To study solely LhaSTA-dependent 137 
effects, we disabled all known heme import activity in S. lugdunensis by creation of a deletion mutant 138 
lacking the entire isd operon (from the atl gene to isdB, Fig. 1A). Then we expressed lhaSTA under the 139 
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control of its native promoter on a recombinant plasmid in the Δisd background. S. lugdunensis has 140 
been reported to degrade nutritional heme in an IsdG-independent fashion due to an unknown enzyme 141 
(OrfX) [19]. Therefore, we speculated that heme degradation in this strain might still be possible. 142 
LhaSTA deficient and proficient strains showed comparable growth in the presence of FeSO4 (Figure 143 
1 - figure supplement 1). However, only the lhaSTA expressing strain was able to grow in the presence 144 
of heme as sole source of nutrient iron (Fig. 3A). To further support a role for LhaSTA in iron import, 145 
we isolated the cytosolic fraction of the strains prior and after incubation with heme and measured iron 146 
levels using the ferrozine assay [20]. Consistently, we found that LhaSTA expression increased 147 
cytosolic iron levels post incubation with heme (Fig. 3B). These data suggest that LhaSTA represents 148 
a “bona fide” and functional autonomous iron acquisition system.  149 
 150 
LhaSTA enables acquisition of heme from various host hemoproteins 151 
 We wondered how S. lugdunensis might benefit from a heme specific ECF-transporter when a 152 
heme acquisition system is already encoded by the canonical Isd system. Indeed, Isd represents a 153 
highly effective heme acquisition system. Interactions between the surface receptor IsdB and the 154 
proteinaceous part of hemoglobin are thought to enhance heme release to increase its availability [21, 155 
22]. The downside of this mechanism is the specificity for hemoglobin because heme derived from 156 
other host hemoproteins such as myoglobin remains inaccessible. In contrast, the HasA hemophore 157 
produced by Gram negative pathogens is reported to bind heme with sufficient affinity to enable heme 158 
acquisition from a range of host hemoproteins without the need of protein-protein interactions to 159 
enhance heme release [23, 24]. As ECF-transporters are known to have high affinity towards their 160 
ligands, we speculated that LhaS might represent a membrane-located high affinity ‘hemophore’ 161 
allowing heme acquisition from hemoproteins other than hemoglobin. We explored this idea using the 162 
hemoprotein myoglobin which is abundant in muscle tissues. Myoglobin was previously reported to 163 
not interact with S. lugdunensis IsdB [16] and is therefore unlikely to be a substrate for the Isd system. 164 
We analyzed the growth of the S. lugdunensis wild type (WT) strain as well as of the isogenic lhaSTA 165 
deficient strain (Fig 4A) on human hemoglobin (hHb) or on equine myoglobin (eqMb) as sole sources 166 
of nutrient iron (Fig. 4B). Unlike the WT strain, the lhaSTA deficient strain displayed a mild 167 
7 
 
proliferation defect on hHb and a pronounced growth defect on equine eqMb (Fig. 4B). Interestingly, 168 
lhaSTA deficiency did not impact proliferation on hemoglobin-haptoglobin (Hb-Hap) complexes 169 
suggesting Isd-dependent acquisition of heme from Hb-Hap. These data strongly indicate that LhaSTA 170 
possesses a hemoprotein substrate range that differs from that of the Isd system. To further validate 171 
this, we used the above-described S. lugdunensis isd mutant expressing lhaSTA (Fig. 4A) and tested its 172 
ability to proliferate on a range of different hemoproteins. (Fig. 4C). We found that lhaSTA expression 173 
enabled growth on hemoglobin (human and murine origin) and myoglobin (human and equine origin) 174 
as well as with hemopexin (Hpx). Consistent with the above observations, Hb-Hap complexes did not 175 
enable growth of the lhaSTA proficient strain strengthening the notion that Hb-Hap acquisition is Isd-176 
dependent. These data further indicate that LhaSTA allows extraction and usage of heme from a 177 
diverse set of host hemoproteins, thus expanding the range of hemoproteins accessible to S. 178 
lugdunensis. 179 
 To confirm the activity of LhaSTA at the biochemical level, we isolated E. coli-derived 180 
membrane vesicles that carried apo-LhaS. Following incubation of the vesicles with or without 181 
different host hemoproteins, LhaS was purified using affinity chromatography. Heme saturation of 182 
LhaS was assessed using SDS-PAGE and tetramethylbenzidine (TMBZ) staining, a reagent that turns 183 
green in the presence of hemin-generated peroxides [25] (Fig. 4D). In the absence of hemoproteins 184 
during incubation, apo-LhaS did not stain with TMBZ, but TMBZ staining was observed after 185 
incubation with all the hemoproteins tested except for Hb-Hap. These data nicely correlate with the 186 
ability of the lhaSTA proficient strain to grow on all hemoproteins but Hb-Hap complexes. 187 
 188 
LhaSTA allows usage of human host hemoproteins as an iron source 189 
 Usage of host derived hemoproteins requires the combined action of hemolytic factors to 190 
damage host cells as well as hemoprotein acquisition systems to use the released hemoproteins. Since 191 
we realized that the S. lugdunensis N920143 strain is non-hemolytic on sheep blood agar, we 192 
reproduced the Δisd deletion as well as the plasmid-based expression of lhaSTA in the hemolytic S. 193 
lugdunensis N940135 strain. As for N920143, LhaSTA-dependent usage of hemoproteins was also 194 
observed in the N940135 background (Figure 4 - figure supplement 1). 195 
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 We speculated that the expression of LhaSTA is beneficial to S. lugdunensis during invasive 196 
disease as it allows usage of a wide range of hemoproteins as iron sources. To test this, we attempted 197 
to establish septic disease models for S. lugdunensis. However, we found that S. lugdunensis N940135 198 
was unable to establish systemic disease in mice. Even when infected with 3*107 CFU/animal, mice 199 
did not show signs of infection (weight loss / reduced movement). Three days post infection, the 200 
organs of infected animals showed low bacterial burdens frequently approaching sterility (Figure 5 - 201 
figure supplement 1) and the expression of LhaSTA did not increase the bacterial loads within the 202 
organs. We speculate that the presence of human-specific but lack of mouse-specific virulence factors 203 
might reduce S. lugdunensis pathogenesis in mice. Little is known about virulence factors encoded by 204 
S. lugdunensis, however, human specific toxins that lyse erythrocytes to release nutritional 205 
hemoglobin have previously been described for S. aureus [26]. To further assess this, we performed 206 
hemolysis assays using human as well as murine erythrocytes (Figure 5 - figure supplement 2). 207 
Hemolytic activity of S. lugdunensis culture filtrates was low compared to those of S. aureus. 208 
Nevertheless, we observed lysis of human erythrocytes while murine erythrocytes were not affected by 209 
S. lugdunensis culture filtrates. This suggests human specific factors mediating host cell damage 210 
(Figure 5 - figure supplement 2).  211 
 Therefore, we used an ex-vivo model to investigate whether LhaSTA facilitates the usage of 212 
human cells as a source of iron. First, we supplied freshly isolated human erythrocytes as a source of 213 
hemoglobin. Figure 5A shows, that the presence of human erythrocytes allowed significantly 214 
improved growth of the Isd deficient but LhaSTA-expressing strain. Secondly, we used a human 215 
cardiac myocyte cell line as a source of iron. S. lugdunensis is associated with infective endocarditis 216 
and myocytes are a source of myoglobin which can be acquired via LhaSTA. Indeed, we found that 217 
lhaSTA expression enhanced the growth of S. lugdunensis in the presence of cardiac myocytes. 218 
 In conclusion, our results suggest that LhaSTA represents a novel broad-range heme-219 
acquisition system that expands the hemoprotein substrate range accessible to S. lugdunensis to 220 
overcome nutritional iron restriction (Fig. 6). 221 
 222 
Discussion  223 
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 Nutritional iron restriction represents an effective host strategy to prevent pathogen 224 
proliferation within sterile tissues. In turn, bacterial pathogens have developed a range of strategies to 225 
overcome nutritional iron limitation during infection. Amongst these is the production and acquisition 226 
of siderophores which scavenge the smallest traces of molecular iron to make it biologically available. 227 
The highly virulent S. aureus species produces the siderophores staphyloferrin A (SF-A) and 228 
staphyloferrin B (SF-B) which are important during infection [27, 28]. S. lugdunensis is associated 229 
with a series of cases of infective endocarditis and the course of disease mimics that of S. aureus 230 
endocarditis. In contrast to S. aureus, S. lugdunensis does not produce endogenous siderophores [29], 231 
suggesting that the iron requirements during infection must be satisfied through alternative strategies. 232 
Host hemoproteins can be used by pathogens to acquire iron-containing heme and a plethora of 233 
hemoproteins are available during infection. Hemoglobin or myoglobin becomes available if the 234 
intracellular pool of the host is tapped by secretion of hemolytic factors. Alternatively, host hemopexin 235 
or hemoglobin-haptoglobin complexes involved in heme/hemoglobin turnover are extracellularly 236 
available to pathogens. Host hemoproteins are characterized by a remarkable affinity towards heme: 237 
Both, globin and hemopexin bind heme with dissociation constants (Kds) smaller than 1 pM [30, 31]. 238 
The usage of heme by invasive pathogens is widely distributed, however, the molecular pathways and 239 
hemoprotein range availability differs dramatically (see [9] for an excellent review). Iron dependent 240 
surface determinant loci are used to acquire heme from hemoglobin by several Gram positive 241 
pathogens including S. aureus [32], S. lugdunensis [11, 12], Bacillus anthracis [33], Streptococcus 242 
pyogenes [34] and Listeria monocytogenes [35].  243 
 ABC transporters of the Energy-coupling factor type (ECF) are trace element acquisition 244 
systems [3, 4]. ECF-type transporters are characterized by high affinity towards their ligands and ECF 245 
systems specific for the vitamins riboflavin [36], folate [37], thiamine [38], biotin [39], cobalamine 246 
[40, 41], pantothenate [42, 43], niacin [44] and pyridoxamine [45] as well as for the trace metals nickel 247 
and cobalt [46, 47] have been described. However, ECF-transporters that allow iron acquisition have 248 
so far remained elusive. 249 
 Now we show that S. lugdunensis encodes the iron regulated ECF-transporter LhaSTA. LhaS 250 
binds heme and enables accumulation of iron within the cytoplasm. Therefore, the system represents a 251 
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novel type of “bona fide” iron acquisition system. Recombinant LhaS acquired heme from human and 252 
murine hemoglobin, from human and equine myoglobin as well as from human hemopexin. The 253 
ability of LhaS to accept heme from several sources strongly suggest an affinity-driven mechanism 254 
relying on passive diffusion of heme between proteins rather than on active extraction. Such a 255 
mechanism has been suggested for HasA-type hemophores of Gram negative pathogens such as 256 
Serratia marcescens, Yersina pestis and Pseudomonas aeruginosa [48, 49]. Similar to LhaS, HasA has 257 
been shown to possess a broad hemoprotein substrate range and allows the usage of hemoglobin from 258 
different species as well as myoglobin and hemopexin [48]. This ability of HasA was attributed to its 259 
high affinity towards heme (Kd = 0.2 nM) [23]. ECF-specificity subunits frequently possess Kds 260 
towards their ligands in the low nanomolar to picomolar range [4], supporting the idea that LhaS 261 
might directly accept heme from hemoproteins. We attempted isothermal titration calorimetry to 262 
determine the affinity of LhaS towards heme, but our efforts failed to deliver a precise Kd. However, 263 
co-purification of heme with heterologously expressed LhaS suggests that the off-rates are low, 264 
consistent with high-affinity binding. Therefore, the system might be superior to heme acquisition 265 
systems, which depend on specific interactions between bacterial hemoprotein-receptors and host 266 
hemoproteins to extract heme. The S. aureus Isd system is well-studied in this regard. The surface 267 
located receptor IsdB binds hemoglobin through its N-terminal NEAT domain (IsdB-N1). This 268 
binding is proposed to induce a steric strain that facilitates heme dissociation. Heme is then captured 269 
by the C-terminal NEAT domain (isdB-N2) and transported across the cell wall and membrane [22, 270 
28, 50-52]. Similarly, the secreted hemophores IsdX1 and IsdX2 of Bacillus anthracis possess NEAT 271 
motifs and perform the same two-step process as IsdB of S. aureus to acquire heme [53]. This 272 
mechanism harbours the disadvantage of facilitating heme acquisition only from a single hemoprotein. 273 
IsdB allows acquisition from hemoglobin but does not interact with myoglobin or hemopexin [51] and 274 
even hemoglobin from different species reduces the efficacy of the system [54, 55]. The same is true 275 
for IsdB of S. lugdunensis [16]. Haemophilus influenza uses the specific interaction between the 276 
surface exposed receptor HxuA and hemopexin to facilitate heme dissociation. Heme is subsequently 277 
captured by HxuC [56, 57]. Again, the specificity for hemopexin prevents usage of other hemoproteins 278 
by HxuA. Specific interactions between LhaS and multiple host hemoproteins seem unlikely, 279 
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suggesting that the superior affinity of LhaS towards the heme group bypasses the need for protein-280 
protein interactions and enables usage of different hemoproteins. However, additional experimental 281 
evidence is required to strengthen this hypothesis of passive heme transfer. 282 
 The LhaSTA operon of S. lugdunensis is located within the isd operon which encodes the 283 
hemoglobin receptor IsdB, the cell wall-anchored, heme-binding proteins IsdJ and IsdC as well as the 284 
conventional heme membrane transporter IsdEFL. Deletion of lhaSTA in combination with isdEFL did 285 
not completely abrogate acquisition of free heme. A similar effect has been observed in S. aureus 286 
suggesting the presence of additional, low affinity heme transporters within these species [58]. 287 
Furthermore, a putative secreted/membrane associated hemophore (IsdK) is encoded within the operon 288 
[16]. Interestingly, we show LhaSTA to be functionally independent of the Isd cluster because 289 
LhaSTA-dependent usage of all host hemoproteins except for Hb-Hap was observed in the absence of 290 
all Isd-associated proteins. This indicates that LhaSTA does not rely on Isd-dependent funneling of 291 
heme across the cell wall, but also raises interesting questions about the spatial organization of heme 292 
acquisition and donor proteins. For an efficient transfer of heme between host hemoproteins and LhaS 293 
one would expect that spatial proximity between the proteins is required. Yet, LhaS is situated in the 294 
bacterial membrane and host hemoproteins are too large (hemoglobin ~ 64-16 kd (tetramer-monomer), 295 
myoglobin ~16 kDa, Hemopexin-heme ~70,6 kDa) to readily penetrate the peptidoglycan layer of 296 
Gram-positive bacteria. However, it has been shown that staphylococcal peptidoglycan contains pores 297 
that might allow access of proteins to the bacterial membrane [59, 60]. Along this line, it is tempting 298 
to speculate that surface receptor-dependent acquisition of Hb-Hap might be needed as these 299 
complexes exceed 100 kDa and might be unable to access the bacterial membrane. However, we also 300 
observed that recombinant LhaS did not accept heme from Hb-Hap which might indicate that binding 301 
of haptoglobin to hemoglobin increases the strength of heme binding to the protein complex. Such an 302 
effect of haptoglobin is to our knowledge not known and might be interesting for further investigation. 303 
 We failed to establish a functional mouse model of systemic disease to study the in vivo role of 304 
LhaSTA for the pathogenicity of S. lugdunensis. The reasons for this can be plentiful as little is known 305 
about virulence factors of S. lugdunensis. Genome analysis showed that S. lugdunensis lacks the wide 306 
variety of virulence and immune evasion molecules found in S. aureus [11]. This is the most likely 307 
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explanation for the apparent reduced virulence of S. lugdunensis in mice. Nevertheless, the co-308 
existence of the Isd and LhaSTA heme-acquisition system in this species may represent a virulent trait 309 
and be required for invasive disease. In line with this, most S. lugdunensis strains are highly hemolytic 310 
on blood agar plates suggesting that the release of hemoproteins from host cells can be achieved by 311 
this species. The hemolytic SLUSH peptides [61] of S. lugdunensis resemble the β-PSMs of S. aureus 312 
[62]. Additionally, the sphingomyelinase C (ß-toxin) is conserved in S. lugdunensis [11]. However, 313 
recent research suggested that S. aureus targets erythrocytes specifically using the bi-component 314 
toxins LukED and HlgAB recognising the DARC receptor [26]. This creates human specificity. 315 
Whether similar mechanisms are used by S. lugdunensis is unclear, but we found that, in contrast to 316 
human cells, S. lugdunensis failed to lyse murine erythrocytes. This suggests that host specific 317 
virulence factors are present in S. lugdunensis. Bi-component toxin genes are not located in the 318 
chromosome but genes encoding a streptolysin-like toxin were identified [11].  319 
 We found that LhaSTA facilitated growth of S. lugdunensis in the presence of human cells 320 
such as erythrocytes and myelocytes strongly suggesting that the system allows usage of these cells 321 
during invasive disease. 322 
 Altogether our experiments identify LhaSTA as an ECF-transporter able to acquire iron and 323 
place this important class of nutrient acquisition system in the context of bacterial pathogens and 324 
immune evasion strategies. During the revision of this manuscript Chatterjee and colleagues published 325 
the identification of a heme-specific ECF transporter in streptococci [63]. In addition, a preprint 326 
manuscript that reports the identification of a heme-specific ECF transporter in Lactococcus sakei is 327 
present in bioarchives [64]. Although these transporters seem functionally redundant to the one of S. 328 
lugdunensis described here, the specificity subunits of the systems show remarkably little amino-acid 329 
sequence similarity. This suggests that the genes encoding them might have developed independently 330 
in bacterial species. This was also suggested for the cobalamin-specific components BtuM and CbrT 331 
which bind the same ligand despite little sequence conservation [40]. 332 
 Additional experiments are required to determine whether heme-specific ECF transporters are 333 
also present in other bacterial pathogens and the biochemical properties of heme-binding need to be 334 
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BIO RAD 1560135  
 340 
Chemicals 341 
If not stated otherwise, reagents were purchased from Sigma 342 
 343 
Bacterial strains and growth in iron limited media  344 
All bacterial strains generated and/or used in this study are listed in Table 1. For growth in iron limited 345 
conditions, bacteria were grown overnight in Tryptic Soy Broth (TSB) TSB (Oxoid). Cells were 346 
harvested by centrifugation, washed with RPMI containing 10 µM EDDHA (LGC standards), adjusted 347 
to an OD600 = 1 and 2,5 µl were used to inoculate 0,5 ml of RPMI+ 1 % casamino acids (BACTO) + 348 
10 µM EDDHA in individual wells of a 48 well microtiter plate (NUNC). As sole iron source 200 nm 349 
porcine hemin (Sigma), 2.5 µg/ml human hemoglobin (own preparation), 10 µg/ml human myoglobin 350 
(Sigma) or equine myoglobin (Sigma), 117nM human haptoglobin-hemoglobin or 200 nM 351 
hemopexin-heme (Sigma) were added to the wells. Bacterial growth was monitored using an Epoch2 352 
reader (300 rpm, 37°C). The OD600 was measured every 15 minutes. 353 
 354 
Creation of markerless deletion mutants in S. lugdunensis 355 
For targeted deletion of lhaSTA and isdEFL, 500 bp DNA fragments upstream and downstream of the 356 
genes to be deleted were amplified by PCR. A sequence overlap was integrated into the fragments to 357 
allow fusion and creating an ATG-TAA scar in the mutant allele. The 1 kb deletion fragments were 358 
created using spliced extension overlap PCR and cloned into pIMAY. All the oligonucleotides are 359 
summarized in Supplementary File 1 Targeted mutagenesis of S. lugdunensis was performed using 360 
allelic exchange described elsewhere [65]. The plasmids and the primers used are listed in Table 1 and 361 
Supplementary File 1, respectively. 362 
 363 
Heterologous expression of LhaS and membrane vesicle preparation  364 
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LhaS was overexpressed with a N-terminal deca-His tag using pQE-30 in E. coli XL1 blue in either 365 
Lysogeny broth (LB) medium or RPMI+1% casamino acids. 100 ml overnight culture in LB with 366 
100 μg ml−1 ampicillin was harvested by centrifugation and washed once in PBS. Cells were 367 
resuspended in 5 ml PBS and used for inoculation of 2 L RPMI + 1% casamino acids or LB 368 
medium. Cells were allowed to grow at 37°C to an OD600 = 0.6 - 0.8. Expression was induced by 369 
adding 0.3 mM IPTG for 4 – 5 h at 25°C. Cells were harvested, washed with 50 mM potassium 370 
phosphate buffer (KPi) pH 7.5, and lysed through 3 rounds of sonification (Branson Digital 371 
Sonifier; 2 min, 30% amplitude), in presence of 200 μM PMSF, 1 mM MgSO4 and DNaseI. Cell 372 
debris were removed by centrifugation for 30 min at 7000 rpm and 4°C. The supernatant was 373 
centrifuged for 2 h at 35000 rpm and 4 °C to collect membrane vesicles (MVs). The MV pellet was 374 
homogenized in 50 mM KPi pH 7.5 and flash frozen in liquid nitrogen, stored at -80°C and used for 375 
purification. 376 
 377 
Purification of LhaS 378 
His-tagged LhaS MVs were dissolved in solubilisationbuffer (50 mM KPi pH 7.5, 200 mM KCl, 379 
200 mM NaCl, 1% (w/v) n-dodecyl-b-D-maltopyranosid (DDM, Roth) for 1 h at 4°C on a rocking 380 
table. Non-soluble material was removed by centrifugation at 35000 rpm for 30 min and 4°C. The 381 
supernatant was decanted into a poly-prep column (BioRad) containing a 0.5 ml bed volume Ni2+-382 
NTA sepharose slurry, equilibrated with 20 column volumes (CV) wash buffer (50mM KPi pH 7.5, 383 
200mM NaCl, 50 mM imidazole, 0.04 % DDM) and incubated for 1 h at 4°C while gently agitating. 384 
The lysate was drained out of the column and the column was washed with 40 CV wash buffer. 385 
Bound protein was eluted from the column in 3 fractions with elution buffer (50mM KPi, pH 7.5, 386 
200 mM NaCl, 350 mM imidazole, 0.04 % DDM). The sample was centrifuged for 3 min at 10.000 387 
rpm to remove aggregates and loaded on a Superdex® 200 Increase 10/300 GL gel filtration column 388 
(GE Healthcare), which was equilibrated with SEC buffer (50mM KPi pH 7.5, 200 mM NaCl, 0.04% 389 
DDM). Peak fractions were combined and concentrated in a Vivaspin disposable ultrafiltration 390 




MV saturation with hemoproteins 393 
MVs (120 mg total protein content) from RPMI were thawed and incubated for 10 min at RT with 394 
each of the following molecules: 5.6 µM heme, 476 µg/ml human hemoglobin, 437 µg/ml equine 395 
myoglobin, 5.6 µM hemopexin-heme, 476 µg/ml hemoglobin-haptoglobin. Further purification was 396 
performed as described above. After Ni2+ affinity chromatography the protein was concentrated and 397 
used to measure the peroxidase activity of heme (TMBZ staining). 398 
 399 
TMBZ staining of heme 400 
Protein content was determined by Bradford analysis (BIORAD) according to the manufacturer’s 401 
protocol. 15 µg protein sample was mixed 1:1 with native sample buffer (BIORAD) and loaded on a 402 
Mini-PROTEAN TGX Precast Gel (BIORAD). The PAGE was run at 4°C and low voltage for 2 h 403 
in Tris /Glycine buffer (BIORAD). The gel was rinsed with H2O for 5 min and stained with 50 ml 404 
staining solution (15 ml 3,3',5,5'-tetramethylbenzidine (TMBZ) solution (6.3 mM TMBZ in 405 
methanol) +35 ml 0.25 M sodium acetate solution (pH 5)) for 1 h at room temperature (RT) while 406 
gently agitating. The gel was then incubated for 30 min at RT in the dark in presence of 30 mM 407 
H2O2. The background staining was removed by incubating the gel in a solution of isopropanol/0.25 408 
M sodium acetate (3:7). Following scanning, the gel was completely destained in a solution of 409 
isopropanol/0.25 M sodium acetate (3:7) and stained with the BlueSafe stain (nzytech) for 10 min.  410 
 411 
Preparation of human erythrocytes 412 
Human blood was obtained from healthy volunteers and mixed 1:1 with MACS buffer (PBS w/o + 413 
0.05 % BSA + 2 mm EDTA). Erythrocytes were pelleted by density gradient centrifugation in a 414 
histopaque blood gradient for 20 min 380 x g at RT. The erythrocyte pellet was washed 3 times with 415 
erythrocyte wash buffer (21 mM Tris, 4.7 mM KCl, 2 mM CaCl2, 140.5 mM NaCl, 1.2 mM MgSO4, 416 
5.5 mM Glucose, 0.5 % BSA, pH 7.4). Cell count and viability was determined by using the trypan 417 
blue stain (BIO RAD). 418 
 419 
Purification of human hemoglobin 420 
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Human/murine haemoglobin was purified by using standard procedures describe in detail elsewhere 421 
[66] 422 
 423 
Preparation of saturated hemopexin and haptoglobin 424 
Human hemopexin was dissolved in sterile PBS and saturated with porcine heme in a hemopexin: 425 
heme 1: 1.3 molar ratio for 1 h at 37°C. This was followed by 48 h dialysis in a Slide-a-Lyzer chamber 426 
(ThermoFisher) with one buffer (1 x PBS) change. Haptoglobin was saturated by mixing 4.7 µg/ml 427 
haemoglobin with 8.4 µg/ml human haptoglobin for 30 min at 37°C. 428 
 429 
Quantification of intracellular iron  430 
Bacteria were grown at 37°C in RPMI + 1% casamino acids to an OD600= 0.6. An aliquot of the 431 
culture was collected prior addition of 5 µM heme and 25 µM EDDHA and further incubation at 37°C 432 
for 3 hours. At this time point bacteria were collected and resuspended in buffer WB (10 mM Tris-433 
HCl, pH 7, 10 mM MgCl2, 500 mM sucrose) to an OD600 = 50. The bacterial pellet was collected by 434 
centrifugation at 8000 rpm for 7 min and resuspended in 1 ml buffer DB (10 mM Tris-HCl, pH 7, 10 435 
mM MgCl2, 500 mM sucrose, 0.6 mg/ml lysostaphin, 25 U/ml mutanolysin, 30 μl protease inhibitor 436 
cocktail (1 complete mini tablet dissolved in 1 ml H2O (Roche), 1 mM phenyl-437 
methanesulfonylfluoride (Roth). The cell wall was digested by incubating at 37°C for 1.5 h, followed 438 
by centrifugation at 17000 x g for 10 min at 4°C. Pelleted protoplasts were washed with 1 ml buffer 439 
WB, centrifuged and resuspended in 200 µl buffer LB (100 mM Tris-HCl; pH 7, 10 mM MgCl2, 100 440 
mM NaCl, 100 μg/ml DNaseI, 1 mg/ml RNaseA). Protoplast lysis was performed through repeated 441 
cycles (3) of freezing and thawing. The lysate was centrifuged 30 min to pellet membrane fraction and 442 
recover the supernatant, which contained the cytosolic fraction and was used for quantification of total 443 
intracellular iron content.  444 
Quantification of intracellular iron content by heme uptake was carried out according to Riemer et al. 445 
[20] with minor modifications. Briefly, 100 µl of the cytosolic fraction were mixed with 100 µl 50mM 446 
NaOH, 100 µl HCL, and 100 µl iron releasing reagent (1:1 freshly mixed solution of 1.4 M HCl and 447 
4.5 % (w/v) KMnO4 in H2O). Samples were incubated for 2 h at 60°C in a fume hood. 30 µl iron 448 
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detection reagent (6.5 mM ferrozine, 6.5 mM neocuproine, 2.5 M ammonium acetate, 1 M ascorbic 449 
acid) was mixed with the samples and incubated for 30 min at 37°C while shaking (1100 rpm). 450 
Samples were centrifuged for 3 min at 12000 x g to remove precipitates.  150 µl of the supernatants 451 
were transferred to a 96-well microtiter plate and absorbance at 550 nm was measured in a plate reader 452 
(BMG Labtech). For determination of iron concentration, FeCl3 standards in a range of 0 to 100 µM 453 
were prepared. 454 
 455 
Measurement of LhaS absorption spectra 456 
LhaS was purified from LB (holo LhaS) or RPMI (apo LhaS) as described above. 2µl protein sample 457 
were loaded on an Eppendorf µCuvette and absorptions spectra were measured at 260 - 620 nm with a 458 
BioPhotometer (Eppendorf). 459 
 460 
Characterization of LhaS and heme by mass spectrometry analysis 461 
MALDI-TOF mass spectra were recorded with a Reflex IV (Bruker Daltonics, Bremen, Germany) in 462 
reflector mode. Positive ions were detected and all spectra represent the sum of 50 shots. A peptide 463 
standard (Peptide Calibration Standard II, Bruker Daltonics) was used for external calibration. 2,5-464 
dihydroxybenzoic acid (DHB, Bruker Daltonics) dissolved in water/acetonitrile/trifluoroacetic acid 465 
(50/49.05/0.05) at a concentration of 10 mg ml-1 was used as matrix. Before the measurements, the 466 
samples Lhas-apo (317 µg ml-1) and Lhas+heme (377 µg ml-1) were centrifuged and diluted with 467 
MilliQ-H2O (1:25). An aliquot of 1 µL of the samples was mixed with 1 µL of the matrix and spotted 468 
onto the MALDI polished steel sample plate. As the solution dried, the organic solvent evaporated 469 
quickly. At this point, the remaining mini droplet was removed gently with a pipette and the remaining 470 
sample was air-dried at room temperature. 471 
High resolution mass spectra of Lhas-apo (317 µg ml-1) and Lhas+heme (377 µg ml-1) were recorded 472 
on a HPLC-UV-HR mass spectrometer (MaXis4G with Performance Upgrade kit with ESI-Interface, 473 
Bruker Daltonics). The samples were diluted with MilliQ-H2O (1:25) and 3 µL were applied to a 474 
Dionex Ultimate 3000 HPLC system (Thermo Fisher Scientific), coupled to the MaXis 4G ESI-QTOF 475 
mass spectrometer (Bruker Daltonics). The ESI source was operated at a nebulizer pressure of 2.0 bar, 476 
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and dry gas was set to 8.0 L min-1 at 200 °C. MS/MS spectra were recorded in auto MS/MS mode with 477 
collision energy stepping enabled. Sodium formate was used as internal calibrant. The gradient was 90 478 
% MilliQ-H2O with 0.1 % formic acid and 10 % methanol with 0.06 % formic acid to 100 % methanol 479 
with 0.06 % formic acid in 20 min with a flow rate of 0.3 mL/min on a Nucleoshell®EC RP-C18 (150 480 
x 2 mm, 2.7μm) from Macherey-Nagel.  481 
[M+H]+ calculated for C34H32FeN4O4
+: 616.1767; found 616.1778 (∆ ppm 1.78). 482 
Calculation of binding stoichiometry 483 
To calculate the putative binding stoichiometry of heme and LhaS the heme concentration in Fig.2A 484 
was determined utilizing the extinction coefficient of 58,4 mM-1 cm-1  at 384 nm for heme. The LhaS 485 
concentration was determined utilizing the extinction coefficient of 29910 M-1 cm-1 (calculated with 486 
ProtParam tool – ExPASy) at 280 nm. 487 
 488 
Human Cardiac Myocytes (HCM) 489 
Primary human cardiac myocytes were purchased from PromoCell (the identity of the cell line was not 490 
verified; the culture was negative for mycoplasma) and in 75-cm2culture flasks in 20 ml of myocyte 491 
growth medium (PromoCell). Cells were detached with accutase, washed once with RPMI containing 492 
200 µM EDDHA and resuspended in PRMI containing 200 µM EDDHA. 40000 cells per well were 493 
used for bacterial growth assays as described above. 494 
 495 
Assessing hemolytic activity of S. lugdunensis culture supernatants 496 
S. aureus and S. lugdunensis were grown overnight in TSB. Cells were pelleted and culture 497 
supernatants were filter sterilized using a 0.22 μM filter. A 100 μL volume of supernatant was added 498 
into 1 mL of PBS containing either 5% v/v murine or human red blood cells. Mixtures were incubated 499 
at room temperature without shaking for 48 hours. 500 
 501 
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Figure 1. LhaSTA represents an iron-regulated heme transporter. 689 
A) Schematic diagram of the isd operon of S. lugdunensis N920143. Coding sequences, direction of 690 
transcription and Fur-binding sites are indicated. ABC membrane-transporters are shown in green. 691 
lhaS - SLUG_00900; lhaT - SLUG_00910; lhaA - SLUG_00920 692 
B) Iron-regulated expression of Lha: S. lugdunensis was grown overnight in TSB, TSB + 200 µM 693 
EDDHA or TSB + 200 µM EDDHA + 200 µM FeSO
4
. Gene expression was quantified by qPCR. 694 
Expression was normalized to 5srRNA and to the TSB standard condition using the ΔΔCt method. 695 
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Fold differences in gene expression are shown. Data represent mean and SD of four independent 696 
experiments. Statistical evaluation was performed using students unpaired t-test (lhaS: t=7,045, df=6; 697 
lhaA: t=2,979, df=6) 698 
C/D Growth curves of S. lugdunensis N920143 and isogenic mutants. The wild type (WT) S. 699 
lugdunensis N920143 strain and the indicated isogenic null mutant strains were grown in the presence 700 
of 20 µM FeSO
4
 (C) or 150 nM heme (D) as a sole source of iron. 500 µl of bacterial cultures were 701 
inoculated to an OD
600
= 0,05 in 48 well plates and OD
600
 was monitored every 15 min using an 702 
Epoch1 plate reader. For reasons of clarity values taken every 5 hours are displayed. Mean and SD of 703 
three experiments are shown. Statistical analysis was performed using one-way ANOVA followed by 704 
Dunett’s test for multiple comparisons.  * - p < 0,05, **** p < 0,00001 705 
 706 
Figure 1- figure supplement 1. LhaSTA dependent growth. 707 
A/B) Proliferation of S. lugdunensis N920143 ∆isd pRB473 and ∆isd pRB473:lhaSTA strains. The 708 
indicated strains were grown in the absence of nutritional iron (A) or in the presence of 20 µM FeSO
4 
709 
(B). 500 µl of cultures were inoculated to an OD
600
= 0,05 in 48 well plates and OD
600
 was monitored 710 
every 15 min using a Epoch1 plate reader. For reasons of clarity values taken every 5 hours are 711 
displayed. Mean and SD of three experiments are shown. Statistical analysis was performed using 712 
students unpaired t-test. 713 
 714 
Figure 2. LhaS binds heme. 715 
A) Ultraviolet-visible (UV-vis) spectrum of recombinant LhaS. C-terminal His-tagged LhaS was 716 
heterologously expressed in E. coli and purified from heme-containing LB medium or heme-free 717 
RPMI medium. The UV-vis spectrum of the purified LhaS was measured with a BioPhotometer. 718 
B) and C) MALDI-TOF mass spectra of recombinant LhaS. LhaS (B) was purified out of LB 719 
medium and apo-LhaS (C) was purified out of RPMI medium. Mass spectra were recorded with a 720 
Reflex IV in reflector mode. All spectra are a sum of 50 shots. Prior to measurements the protein 721 
samples were mixed with a 2,5-dihydroxybenzoic acid matrix dissolved in 722 
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water/acetonitrile/trifluoroacetic acid (50/49.05/0.05) at a concentration of 10 mg ml
-1
 and spotted 723 
onto the MALDI polished steel sample plate. 724 
 725 
Figure 2 – figure supplement 1. High resolution mass spectra of apo- and holo-LhaS. 726 
Spectra of apo-LhaS isolated from E.coli grown in RPMI medium (upper panel), holo-LhaS isolated 727 
from LB-medium (middle panel) and a heme standard (lower panel) were recorded on a HPLC-UV-728 
HR mass spectrometer. The samples were diluted with MilliQ-H
2
O and applied to a Dionex Ultimate 729 
3000 HPLC system that is coupled to the MaXis 4G ESI-QTOF mass spectrometer.  730 
 731 
Figure 3. LhaSTA represents a functionally autonomous iron acquisition system. 732 
A) LhaSTA-dependent proliferation. S. lugdunensis N920143 deletion mutant strains lacking the 733 
entire isd operon and expressing LhaSTA (∆isd pRB473:lhaSTA) or not (∆isd pRB473) from the 734 
plasmid pRB473 were grown in the presence of 200 nM heme as a sole source of iron. 500 µl of 735 
cultures were inoculated to an OD
600
= 0,05 in 48 well plates and OD
600
 was monitored every 15 min 736 
using an Epoch1 plate reader. For reasons of clarity values taken every 5 hours are displayed. Mean 737 
and SD of three experiments are shown. Statistical analysis was performed using students unpaired t-738 
test.  *** p < 0,0001   739 
B) Intracellular accumulation of iron. Strains were grown in iron limited medium to OD600= 0,6 and 740 
5 µM heme were added for 3 h. Cell fractionation of 1 ml OD600 = 50 was performed and the iron 741 
content of the cytosolic fraction was determined using the ferrozine assay. Data represent the mean 742 
and SD of three independent experiments. Statistical analysis was performed using students unpaired 743 
t-test (t=5,12729, df=4). 744 
 745 
Figure 4. LhaSTA facilitates heme acquisition from a wide range of hemoprotein substrates. 746 
A) Schematic diagram of known heme acquisition systems in the S. lugdunensis mutant strains 747 
lacking either the genes encoding LhaSTA (∆lhaSTA, left) or the entire isd operon and 748 
expressing LhaSTA from the plasmid pRB473 (∆isd pRB473:lhaSTA). ABC membrane 749 
transporters are shown in green. Cell wall-anchored proteins of the Isd-system are shown in yellow. 750 
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Heme/hemoglobin-binding NEAT motifs within each protein are indicated as black boxes.  Black 751 
arrows indicate the transfer of heme.  he: heme; hb: hemoglobin; PG: peptidoglycan.  752 
B) Growth of S. lugdunensis N920143 wild type (WT) and ∆lhaSTA. Strains were grown in the 753 
presence of 20 µM FeSO
4 
or 2.5 µg/ml human hemoglobin (hHb) or 10 µg/ml equine myoglobin 754 
(eqMb) or 117 nM hemoglobin-haptoglobin complex (Hb-Hap) as a sole source of iron. 500 µl of 755 
cultures were inoculated to an OD
600
= 0,05 in 48 well plates and OD
600
 was measured after 30 h using 756 
an Epoch1 plate reader. Mean and SD of three experiments are shown. Statistical analysis was 757 
performed using students unpaired t-test. hHb - t=6,0007, df=4;   eqMb – t=20,52, df=4; Hb-Hap – 758 
t=1,978, df=4. 759 
C) Growth of S. lugdunensis N920143 ∆isd pRB473 and ∆isd pRB473:lhaSTA. Strains were grown 760 
in the presence of 20 µM FeSO
4 
or 2.5 µg/ml hHb or 2.5 µg/ml murine hemoglobin (mHb) or 10 761 
µg/ml human myoglobin (hMb) or 10 µg/ml eqMb or 200 nM human hemopexin (Hpx) or 117 nM 762 
Hb-Hap as a sole source of iron. 500 µl of cultures were inoculated to an OD
600
= 0,05 in 48 well plates 763 
and OD
600
 was measured after 30 h using an Epoch1 plate reader. Mean and SD of three experiments 764 
are shown. Statistical analysis was performed using students unpaired t-test hHb – t=18,5, df=4; mHb 765 
– t=29,03, df=4; hMb – t=25,98, df=4; eqMb – t=3,442, df=4; Hpx – t=77,12 df=4; Hb-Hap t=2,758 766 





 stain of TGX gels for heme-associated peroxidase activity. Membrane vesicles 768 
were saturated with excess of hemoprotein (5.6 µM heme, 476 µg/ml hHb, 437 µg/ml eqMb, 5.6 µM 769 
Hpx, 476 µg/ml Hb-Hap) or no hemoprotein (-) for 10 min at RT. LhaS was purified, 15 µg protein 770 




 (upper panel). Gels 771 
were destained and subsequently stained with BlueSafe (lower panel) to confirm the presence of the 772 
protein in all conditions. 773 
 774 
Figure 4 – figure supplement 1. Growth of S. lugdunensis N940135 ∆isd pRB473 and ∆isd 775 
pRB473:lhaSTA. The indicated strains were grown in the presence of 20 µM FeSO
4 
or 2.5 µg/ml 776 
human hemoglobin (hHb), 2.5 µg/ml or murine hemoglobin (mHb) or 10 µg/ml human myoglobin 777 
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(hMb) or 10 µg/ml equine myoglobin (eqMb) or 200 nM human hemopexin (Hpx) or 117 nM Hb-Hap 778 
as a sole source of iron. 500 µl of cultures were inoculated to an OD
600
= 0,05 in 48 well plates and 779 
OD
600
 was measured every 15 min. For reasons of clarity values taken every 5 hours are displayed. 780 
Mean and SD of three experiments are shown. Statistical analysis was performed using students 781 
unpaired t-test.  782 
 783 
Figure 5. LhaSTA allows usage of host cells as an iron source. 784 
A) Growth of S. lugdunensis N940135 ∆isd pRB473:lhaSTA and ∆isd pRB473 on human 785 
erythrocytes. Strains were grown in the presence of freshly isolated human erythrocytes (10
5
 cells/ml) 786 
as a sole source of iron. 500 µl of cultures were inoculated to an OD
600
= 0,05 in 48 well plates and 787 
OD
600
 was monitored every 15 min using an Epoch1 plate reader. For reasons of clarity values taken 788 
every 5 hours are displayed. Mean and SD of three experiments are shown. Statistical analysis was 789 
performed using students unpaired t-test.  *** p < 0,0001  790 
B) Growth of S. lugdunensis N940135 ∆isd pRB473 and ∆isd pRB473:lhaSTA on human cardiac 791 
myocytes. Strains were grown in the presence of 40000 primary human cardiac myocytes per well as a 792 
sole source of iron. Cardiac myocytes were detached and washed once with RPMI+200µM EDDHA 793 
prior addition to the wells. 500 µl of cultures were inoculated to an OD
600
= 0,05 in 48 well plates and 794 
OD
600
 was monitored every 15 min using an Epoch1 plate reader. For reasons of clarity values taken 795 
every 5 hours are displayed. Mean and SD of three experiments are shown. Statistical analysis was 796 
performed using students unpaired t-test.  * p < 0,05, ** p < 0,01 797 
 798 
Figure 5 - figure supplement 1. Mouse systemic infection model.  799 
C57BL/6 mice were infected either with 3 x 10
7
 CFU per animal. Mice were sacrificed 72h post 800 
infection and CFUs within the indicated organs enumerated. Horizontal lines show the median. 801 
Statistical analysis was performed using Mann Whitney test.  802 
 803 
Figure 5 - figure supplement 2. Hemolysis of human and mouse erythrocytes. 804 
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Human (left and middle panels) or mouse erythrocytes (right panel) were incubated with the filtrated 805 
culture supernatants of S. aureus (left panel) or S. lugdunensis (middle and right panels) for 24 and 48 806 
h.  807 
 808 
Figure 6. Model of heme acquisition in S. lugdunensis. 809 
ABC membrane transporters are shown in green. Cell wall-anchored proteins of the Isd-system are 810 
shown in yellow. Heme/hemoglobin-binding NEAT motifs within each protein are indicated as black 811 
boxes.  Black arrows indicated the transfer of heme. he: heme; hb: hemoglobin; PG: peptidoglycan; 812 
Mem: Membrane; Hap: Haptoglobin; Hpx:Hemopexin; Atl: Autolysin. 813 
 814 
Supplementary File 1. Key Resource Table PCR primers. 815 
PCR and qPCR primers sequences used in this study. 816 
atl isdG srtB isdL isdF isdE isdK isdC isdJ lhaA lhaT lhaS isdB
fur boxes fur boxes
150 nM heme
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